| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 163.12B | 184.47B | 154.22B | 127.61B | 106.60B | 94.47B |
| Gross Profit | 103.50B | 116.50B | 98.59B | 84.00B | 70.74B | 61.51B |
| EBITDA | 10.84B | 14.46B | 10.16B | 9.32B | 6.58B | 7.23B |
| Net Income | 2.72B | 3.77B | 2.19B | 2.92B | 1.26B | 1.11B |
Balance Sheet | ||||||
| Total Assets | 106.69B | 140.79B | 104.16B | 91.12B | 79.70B | 76.96B |
| Cash, Cash Equivalents and Short-Term Investments | 15.93B | 30.68B | 16.87B | 19.12B | 14.88B | 13.39B |
| Total Debt | 39.37B | 54.98B | 35.37B | 26.59B | 21.12B | 20.37B |
| Total Liabilities | 60.78B | 83.12B | 58.54B | 47.25B | 38.29B | 36.36B |
| Stockholders Equity | 45.91B | 57.67B | 45.62B | 43.87B | 41.40B | 40.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.35B | -6.20B | 4.08B | 2.75B | 3.55B |
| Operating Cash Flow | 0.00 | 14.94B | 8.32B | 13.24B | 8.65B | 8.84B |
| Investing Cash Flow | 0.00 | -26.54B | -17.76B | -11.89B | -6.57B | -5.70B |
| Financing Cash Flow | 0.00 | 26.06B | 7.14B | 2.74B | -595.65M | -3.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥974.59B | 26.13 | 13.08% | 0.76% | 3.46% | 13.52% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥611.87B | 34.15 | 9.53% | 0.55% | 12.02% | 20.18% | |
61 Neutral | ¥195.36B | 41.97 | ― | 0.69% | 10.09% | 22.64% | |
58 Neutral | ¥124.24B | 35.67 | ― | 0.63% | 6.86% | 182.73% | |
53 Neutral | ¥93.47B | 24.09 | ― | 0.37% | 19.62% | 71.58% | |
50 Neutral | ¥314.13B | 135.97 | ― | 0.24% | 3.91% | 37.17% |